Virax Biolabs Group Ltd Capital Reserve
Virax Biolabs Group Ltd (VRAX) had Capital Reserve of $30.17 million as of 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Notes
ifrs-full:CapitalReserve · last filed 2025-07-02
- 2025-03-31: Capital Reserve $30.17M.
- 2024-03-31: Capital Reserve $23.89M.
- 2023-03-31: Capital Reserve $20.92M.
- 2022-03-31: Capital Reserve $5.36M.
| Period end | Capital Reserve |
|---|---|
| 2025-03-31 | $30.17M 20-F · filed 2025-07-02 |
| 2024-03-31 | $23.89M 20-F · filed 2025-07-02 |
| 2023-03-31 | $20.92M 20-F · filed 2024-08-20 |
| 2022-03-31 | $5.36M 20-F · filed 2023-06-14 |
| 2021-03-31 | $4.03M 20-F · filed 2022-08-12 |